Navigation Links
Common Anaesthetic Drug Can Kill Brain Cells

The commonly used anaesthetic isoflurane could kill brain cells and raise the risk of Alzheimer's, suggests a new study questioning the safety of the drug.

Isoflurane is an anaesthetic, which is inhaled and used when general anaesthesia is required. //

Many people, especially the elderly, suffer from postoperative cognitive dysfunction after anaesthesia as well as scrambling and delirium that can last six hours or two weeks or months, reported the health portal HealthCentral.

'To me, a big dose of isoflurane mimics a stroke or a bang to the head, and you don't want that as a risk factor for Alzheimer's disease at any age,' said Rudolph Tanzi of the Massachusetts General Institute for Neurodegenerative Disease who led the study.

Tanzi's team exposed cells that had an amyloid-beta protein, a protein that restores brain function, to isoflurane for six hours.

The researchers found that isoflurane caused these cells to die. 'It also caused the cell to overproduce the toxic molecule responsible for the pathology of Alzheimer's disease, particularly amyloid-beta,' Tanzi said.

This is a warning, he said. 'Isoflurane may be one reason why the elderly are more prone to cognitive dysfunction following anaesthesia.'

The researcher believes that isoflurane should be avoided when possible. 'We don't have enough data yet to ban isoflurane... But I'm convinced enough that I won't let my mother have it. I would advise any family or friends to stay away from isoflurane.'

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Common contraception
2. Common Cold Remedy May Treat SARS
3. Common Plant Triggers Asthma
4. Pain Common in People with MS
5. Common Cold Found to Fight Cancer
6. Bullying – a Common Problem Among Childre
7. Common Medication Errors in Children
8. A Common Cause Of Allergy That Goes Unnoticed
9. Genetic Breakthrough in Common Eye Problem
10. Common Cold Found to Fight Cancer Cells
11. Side Effects Of Some Common Drugs
Post Your Comments:
(Date:12/2/2008)... SPEAK to collect and dissemina... Bellevue, Wash. (PRWEB) December 2...ed the launch of a new initiative to focus public ...ness . The official kick-off of SPEAK will occur d...cists (ASHP) 2008 Midyear Clinical Meeting, to be ...
(Date:12/2/2008)... Marathon Health, a leading pro...utions, has announced that New Balance, the athlet...to develop, implement and manage onsite health cli...New Balance facilities in Maine , ...- Marathon Health, a leading provider of onsite em...
(Date:12/2/2008)... Development of Normal Gait Dev...erebral Palsy will be the focus of a three-day wor...Dec. 5 through 7. , Chica...Normal Gait Deviations and Treatment Options for t...a three-day workshop to be held at La Rabida Child...
(Date:12/2/2008)...GTON, Dec. 2 Population...omprehensive project that could dramatically reduc...from malaria. The program will provide free artemi...ocal community health workers to poor children sus...oach to treatment will be monitored to determine i...
Breaking Medicine News(10 mins):Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 3Health News:La Rabida Children's Hospital to Host Three-Day Course on Gait Treatment Options for Children with Cerebral Palsy 2Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 2Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 3
...r pollution which has attained critical levels com...of public holidays. All the organizations in the c...05. The primary, junior high schools, and kinderga...the Government, while the elderly and those who su...
...e it is the turn of fructose to be blamed for obes... in the University of Flroda and the findings poin...er natural sources might be the cause of obesity i...makes beleive that the subject is hungrier than ac...
...-known fact that broccoli has cancer fighting prop...blunted in some individuals by the virtue of their...ood Research study. In order to overcome this hur...i." This contains a bigger quantity of the cancer ...
... refused help, say paramedics The disabled, homel...er over the weekend// in sub-zero temperatures had...ccording to BC ambulance Service sources, the para...id actually respond to the call. They did make con...
Other Medicine News:Health News:Fructose is a tricker and not all that sweet! 2Health News:“Super Broccoli” Could Confer Better Cancer Protecti 2
(Date:11/25/2008)...areness can improve recovery , , Audio and ...ailable on the Mayo Clinic News Blog. Please see t..., ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewsw...roke patients don,t think they,re having a stroke ...l their condition worsens. The findings appear in ...
(Date:11/25/2008)...FRANCISCO, Calif., Nov. 25 Proteol...nt of novel therapeutics that target,protein degr..., today,announced that data from two ongoing Phas...eloma will be presented at the upcoming 50th Annua...ASH). Carfilzomib is the first in a new class,of...
(Date:11/25/2008)...ts Enrolled in Clinical Trial to Assess Survival o...Therapies for Unresectable Hepatocellular Carcinom... -- Light Sciences Oncology, Inc. (LSO) today anno...se 3 clinical trial of Light Infusion Therapy(TM) ...ellular carcinoma (HCC), also known as hepatoma or...
(Date:11/24/2008)... Mich., Nov. 24 Domino,s Pizza (NY... delivery, is gearing up to raise dough for,the k...g its fifth annual,Thanks and Giving campaign. Do...e a donation at point of purchase to benefit the c...rdering over the phone or when ordering online at,...
Breaking Medicine Technology:Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman 8579 1Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman 8579 2assisTek 26apos 3Bs ePRO Biotech Clinical Trial Data Collection Saves Client 241 6 Million Over Paper Questionnaires 27693 1assisTek 26apos 3Bs ePRO Biotech Clinical Trial Data Collection Saves Client 241 6 Million Over Paper Questionnaires 27693 2Building the blood brain barrier 5577 1Purple tomatoes 3A The richness of antioxidants against tumors 5574 1Purple tomatoes 3A The richness of antioxidants against tumors 5574 2Purple tomatoes 3A The richness of antioxidants against tumors 5574 3
...Jun 19, 2007 - Javelin,Pharmaceuticals (AMEX: JAV)...ne(TM) (intranasal morphine) successfully met its,...ensity Difference,(SPID) scores over 0-24 hours po...3 studies, patients with moderate-to-severe pain,a... Rylomine every,hour as needed, 15 mg Rylomine eve...
...a Conference , HIGH WYCOMBE, UK 18th June 2007-Pre...a new flu vaccine has the potential,to protect aga...and,annual, was presented today by PepTcell, at th...tions) Conference, in Toronto,Canada. , The pre-c...ropean Journal of Immunology, showed how mice vacc...
Other Medicine Technology:Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 2Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 3Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 4New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 5
The Vitatron Impulse II lead series are silicon rubber endocardial leads specifically designed to extend the longevity of the pacemaker system by providing energy efficient pacing. The high impedance
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl
The Vitatron Excellence SS+ lead series are endocardial silicone leads providing ease of handling and optimal pacing characteristics.
CapSure SP Novus endocardial, tined pacing leads provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but within an even smaller
Medicine Products: